GRAPITOVA GRANULES Sydafrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

grapitova granules

viatris healthcare (pty) ltd - granules - 40,0 mg & 10,0 mg - each sachet contains lopinavir 40,0 mg ritonavir 10,0 mg

MS-30? Stem Cemented - Uncoated hip femur prosthesis, modular Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ms-30? stem cemented - uncoated hip femur prosthesis, modular

zimmer biomet pty ltd - 34190 - uncoated hip femur prosthesis, modular - highly polished stainless steel (protasul?-s30)femoral stem component used in conjunction with a femoral head component for replacement of the proximal femur in total hip arthroplasty. a 12/14 taper is incorporated in the design of the stem to interlock it with the femoral head. it is intended for cemented use only. -noninflammatory degenerative joint disease (nidjd), e.g. avascular necrosis, osteoarthritis, and inflammatory joint disease (ijd), e.g. rheumatoid arthritis. -failed previous surgery where pain, deformity, or dysfunction persists. -revision of previously failed hip arthroplasty.

MS/D, MSX - Magnetic neural stimulation system, stationary Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ms/d, msx - magnetic neural stimulation system, stationary

aimedical international pty ltd - 61160 - magnetic neural stimulation system, stationary - to stimulate the central or peripheral nervous system by using magnetic stimulation, either by application to the cerebral cortex or peripheral nervous system

EllaOne ulipristal acetate 30 mg tablet blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ellaone ulipristal acetate 30 mg tablet blister pack

orion laboratories pty ltd t/a perrigo australia - ulipristal acetate, quantity: 30 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; croscarmellose sodium; lactose monohydrate - ellaone is indicated for emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure.

Sativex Oromucosal Spray, nabiximols 80 mg/mL pump actuated metered dose aerosol Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sativex oromucosal spray, nabiximols 80 mg/ml pump actuated metered dose aerosol

chiesi australia pty ltd - nabiximols, quantity: 80 mg/ml - spray, solution - excipient ingredients: propylene glycol; peppermint oil; ethanol absolute - sativex is indicated as treatment, for symptom improvement in patients with moderate to severe spasticity due to multiple sclerosis (ms) who have not responded adequately to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy.

VAXSAFE MG VACCINE (LIVING) Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vaxsafe mg vaccine (living)

bioproperties pty. ltd. - mycoplasma gallisepticum strain ts-11 - misc. vaccines or anti sera - mycoplasma gallisepticum strain ts-11 vaccine-general active 0.0 ccu/dose - immunotherapy - poultry layers (eggs for human consump) | caged layers | chickens | chooks | hen - chronic respiratory disease | mycoplasma gallisepticum | vaccine | chronic respiratory disease (c | equine rotavirus | infectious sinusitis

PHARMACOR TERIFLUNOMIDE teriflunomide 14 mg film-coated tablets blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pharmacor teriflunomide teriflunomide 14 mg film-coated tablets blister pack

pharmacor pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium starch glycollate type a; hyprolose; colloidal anhydrous silica; lactose monohydrate; maize starch; titanium dioxide; macrogol 8000; hypromellose; purified talc; indigo carmine aluminium lake - teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

SUNITINIB MSN sunitinib (as malate) 37.5 mg hard capsule bottle Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sunitinib msn sunitinib (as malate) 37.5 mg hard capsule bottle

accelagen pty ltd - sunitinib malate, quantity: 50.118 mg (equivalent: sunitinib, qty 37.5 mg) - capsule, hard - excipient ingredients: croscarmellose sodium; mannitol; gelatin; pregelatinised maize starch; titanium dioxide; magnesium stearate; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - sunitinib msn is indicated for;,treatment of advanced renal cell carcinoma (rcc),treatment of gastrointestinal stromal tumour (gist) after failure of imatinib mesilate treatment due to resistance or intolerance,treatment of unresectable, well-differentiated pancreatic neuroendocrine tumours (pancreatic net)